| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Polverini PJ | |
| P2860 | cites work | Tumor Growth and Neovascularization: An Experimental Model Using the Rabbit Cornea 2 | Q53810509 |
| Activated macrophages induce vascular proliferation | Q53988557 | ||
| Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor | Q56429774 | ||
| Angiogenesis in vitro | Q59054949 | ||
| Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α | Q59074915 | ||
| Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells | Q24306649 | ||
| A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas | Q28116420 | ||
| The clonal evolution of tumor cell populations | Q28271546 | ||
| Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1 | Q28508495 | ||
| Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma | Q29615947 | ||
| Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels | Q29619679 | ||
| Requirement of vascular integrin alpha v beta 3 for angiogenesis | Q29619681 | ||
| Angiogenic factors | Q29620582 | ||
| Tumor suppressor genes: the puzzle and the promise | Q33360216 | ||
| A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin | Q33763790 | ||
| Promotion of wound repair in old mice by local injection of macrophages | Q33844850 | ||
| Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells | Q34294419 | ||
| Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion | Q34564640 | ||
| Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 | ||
| Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix | Q34613112 | ||
| The approaching era of the tumor suppressor genes | Q34661392 | ||
| Inhibitors of angiogenesis | Q35308058 | ||
| Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells | Q36217395 | ||
| Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix | Q36218428 | ||
| Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix | Q36220283 | ||
| Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo | Q36220977 | ||
| Angiogenic and invasive properties of neurofibroma Schwann cells | Q36223393 | ||
| Thrombospondin stimulates motility of human neutrophils | Q36224162 | ||
| Regulation of in vitro capillary tube formation by anti-integrin antibodies | Q36233262 | ||
| Tumor dormancy in vivo by prevention of neovascularization | Q36271710 | ||
| Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation | Q36618743 | ||
| Regulators of Angiogenesis | Q36653534 | ||
| Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells | Q36676242 | ||
| Thrombospondins | Q36689844 | ||
| A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis | Q36697002 | ||
| Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis | Q36715134 | ||
| Macrophage-derived angiogenesis factors | Q36936664 | ||
| Embryonic angiogenesis factors | Q36964617 | ||
| MB1, a quail leukocyte-endothelium antigen: partial characterization of the cell surface and secreted forms in cultured endothelial cells | Q37409204 | ||
| Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro | Q37528994 | ||
| Molecular themes in oncogenesis | Q37625792 | ||
| Embryonic origins and assembly of blood vessels | Q38208140 | ||
| Tumor-related angiogenesis | Q38209760 | ||
| A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis | Q38335144 | ||
| Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-beta | Q38705182 | ||
| The pericyte--a review | Q39588793 | ||
| Oncogenes and tumor-suppressing genes | Q39629828 | ||
| Tumor suppressors: recessive mutations that lead to cancer | Q39636917 | ||
| Tumour angiogenesis | Q40109033 | ||
| Genetics of cancer predisposition and progression | Q40835798 | ||
| Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interrelations, and fibrogenesis | Q41103597 | ||
| Angiogenesis: A Marker for Neoplastic Transformation of Mammary Papillary Hyperplasia | Q41232729 | ||
| Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions | Q41257252 | ||
| Stimulation of wound blood vessel growth by wound macrophages | Q41511194 | ||
| In vitro model of angiogenesis using a human endothelium‐derived permanent cell line: Contributions of induced gene expression, G‐proteins, and integrins | Q41593571 | ||
| MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. | Q41681960 | ||
| The biosynthesis of extracellular-matrix components by bovine retinal endothelial cells displaying distinctive morphological phenotypes | Q42010184 | ||
| Macrophages secrete a heparin-binding inhibitor of endothelial cell growth | Q42467433 | ||
| Characterization of wound cytokines in the sponge matrix model | Q42497535 | ||
| Macrophage Vitronectin Receptor, CD36, and Thrombospondin Cooperate in Recognition of Neutrophils Undergoing Programmed Cell Death | Q43539710 | ||
| Initiation and pattern of angiogenesis in wound healing in the rat | Q43823259 | ||
| Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor | Q43932368 | ||
| Interleukin-8 as a macrophage-derived mediator of angiogenesis | Q44053300 | ||
| Neovascularization induced by intraocular xenografts of normal, preneoplastic, and neoplastic mouse mammary tissues | Q44128626 | ||
| Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis | Q44975603 | ||
| Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene | Q45832367 | ||
| Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping | Q46070830 | ||
| Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer. | Q50932556 | ||
| Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. | Q53516782 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathophysiology | Q1135939 |
| P304 | page(s) | 230-247 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Journal of Dental Research | Q6295082 |
| P1476 | title | The pathophysiology of angiogenesis | |
| P478 | volume | 6 |
| Q47774856 | A new, simple stapling technique for pulmonary emphysema: its effects and safety for improving respiratory function |
| Q33489613 | A three species model to simulate application of Hyperbaric Oxygen Therapy to chronic wounds |
| Q39275155 | Abnormal nonstoring capillary endothelium: a novel feature of Gaucher disease. Ultrastructural study of dermal capillaries |
| Q35147199 | Activation of Latent TGF-β1 by Thrombospondin-1 is a Major Component of Wound Repair |
| Q36417732 | Activation of iCaspase-9 in neovessels inhibits oral tumor progression |
| Q77627722 | Adhesion molecules in rheumatoid arthritis |
| Q42601212 | Angiogenic activity of an Onchocerca volvulus Ancylostoma secreted protein homologue |
| Q37701942 | Angiogenic targets for potential disorders |
| Q58796011 | Antenatal IL-1-dependent inflammation persists postnatally and causes retinal and sub-retinal vasculopathy in progeny |
| Q73367975 | Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery |
| Q38109057 | Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement: a future useful tool in assessing clinical outcomes of COPD patients in clinical practice? |
| Q28647132 | Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1 |
| Q40995372 | Cellular adhesion molecules. Newly identified mediators of angiogenesis. |
| Q42469834 | Characterization, Localization and Patterning of Lymphatics and Blood Vessels in Oral Squamous Cell Carcinoma: A Comparative Study Using D2-40 and CD-34 IHC Marker |
| Q35773664 | Charting a new course through the chaos of KS (Kaposi's sarcoma) |
| Q37608615 | Chemokines in tumor-associated angiogenesis. |
| Q43701123 | Connective tissue growth factor in drug-induced gingival overgrowth |
| Q73519347 | Controlled release of vascular endothelial growth factor by use of collagen hydrogels |
| Q34143913 | Delivery of lipoplexes for genotherapy of solid tumours: role of vascular endothelial cells |
| Q77541045 | Does vascular endothelial growth factor in the rheumatoid synovium predict joint destruction? A clinical, radiological, and pathological study in 12 patients monitored for 10 years |
| Q99546600 | EGFR in enterocytes & endothelium and HIF1α in enterocytes are dispensable for massive small bowel resection induced angiogenesis |
| Q84749661 | Effect of bone marrow mesenchymal stem cells transfected with rAAV2-bFGF on early angiogenesis of calvarial defects in rats |
| Q80709524 | Effect of chronic prostatitis on angiogenic activity and serum prostate specific antigen level in benign prostatic hyperplasia |
| Q40642559 | Effect of lipopolysaccharides on vascular endothelial growth factor expression in mouse pulp cells and macrophages |
| Q33768576 | Endodontic-orthodontic relationships: a review of integrated treatment planning challenges |
| Q40902483 | Expression and characterization of novel thrombospondin 1 type I repeat fusion proteins |
| Q38404639 | Expression of vascular endothelial growth factor and microvessel density in oral tumorigenesis |
| Q35809815 | Galectin-3 induces endothelial cell morphogenesis and angiogenesis |
| Q33785869 | Genes and oral cancer |
| Q36375624 | Higher blood vessel density in comparison to the lymphatic vessels in oral squamous cell carcinoma |
| Q41976237 | Histomorphometric Analysis of Angiogenesis using CD31 Immunomarker and Mast Cell Density in Oral Premalignant and Malignant Lesions: A Pilot Study |
| Q37590005 | Histomorphometric analysis of vascularity in normal buccal mucosa, leukoplakia, and squamous cell carcinoma of buccal mucosa |
| Q41372640 | How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases |
| Q42426199 | Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies |
| Q51824939 | Immobilization-induced cartilage degeneration mediated through expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and chondromodulin-I. |
| Q39804972 | Immunohistochemical expression of vascular endothelial growth factor in keratocystic odontogenic tumor, dentigerous cyst, and radicular cyst: A comparative study |
| Q35577528 | Improving anti-angiogenic therapy via selective delivery of cationic liposomes to tumour vasculature |
| Q35109257 | Incidence of mast cells in oral squamous cell carcinoma: a short study |
| Q53471341 | Induction of angiogenesis by airway smooth muscle from patients with asthma. |
| Q36820584 | Inhibition of corneal neovascularization with the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile INTeraction-18 (p-PEDF-SAINT-18) vector in a rat corneal experimental angiogenesis model |
| Q73779435 | Localization and density of myeloid leucocytes in the periodontal ligament of normal rat molars |
| Q89454391 | Microchannel network hydrogel induced ischemic blood perfusion connection |
| Q46885901 | Microvascular remodelling in chronic airway inflammation in mice |
| Q36291833 | Molecular Docking and Interactions of Pueraria Tuberosa with Vascular Endothelial Growth Factor Receptors |
| Q41294983 | Molecular biology of human oral cancer |
| Q81024663 | Molecular pathways in bladder cancer |
| Q35175438 | Molecular prognostication in bladder cancer--a current perspective. |
| Q37681157 | Novel aspects of corneal angiogenic and lymphangiogenic privilege. |
| Q44006366 | Novel bicyclic oxazolone derivatives as anti-angiogenic agents |
| Q26781603 | On the mathematical modeling of wound healing angiogenesis in skin as a reaction-transport process |
| Q42511846 | Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma |
| Q41015545 | Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway |
| Q33636970 | Progesterone receptor activation of extranuclear signaling pathways in regulating p53 expression in vascular endothelial cells |
| Q40574911 | Quantification and Correlation of Angiogenesis with Macrophages by Histomorphometric Method in Central and Peripheral Giant Cell Granuloma: An Immunohistochemical Analysis |
| Q31995022 | Responses of macrophage-associated antigen-expressing cells in the dental pulp of rat molars to experimental tooth replantation |
| Q51749391 | Role of VEGF in small bowel adaptation after resection: the adaptive response is angiogenesis dependent. |
| Q35546661 | Role of endothelial cell survival and death signals in angiogenesis |
| Q38009855 | Role of high endothelial postcapillary venules and selected adhesion molecules in periodontal diseases: a review. |
| Q43189555 | Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering |
| Q36466392 | Silicone hydrogel contact lenses and the ocular surface. |
| Q34090971 | Stimulation of beta 1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration |
| Q38103868 | The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy |
| Q41505806 | The molecular biology of oral carcinogenesis: toward a tumor progression model |
| Q38805034 | Therapeutic application of anti-angiogenic nanomaterials in cancers |
| Q34540278 | Tissue engineered scaffolds in regenerative medicine. |
| Q97644981 | Triiodothyronine potentiates angiogenesis-related factor expression through PI3K/AKT signaling pathway in human osteoarthritic osteoblasts |
| Q36458443 | VEGF: A critical driver for angiogenesis and subsequent tumor growth: An IHC study |
| Q36949564 | VEGF: an essential mediator of both angiogenesis and endochondral ossification |
| Q35745301 | Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression |
| Q48017018 | Vascular endothelial growth pattern during demineralized bone matrix induced osteogenesis |
| Q54589409 | [The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy]. |
Search more.